Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) FCF Margin (2016 - 2025)

Historic FCF Margin for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to 26.94%.

  • Pediatrix Medical's FCF Margin rose 84700.0% to 26.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.48%, marking a year-over-year increase of 81100.0%. This contributed to the annual value of 9.7% for FY2024, which is 40500.0% up from last year.
  • As of Q3 2025, Pediatrix Medical's FCF Margin stood at 26.94%, which was up 84700.0% from 28.79% recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's FCF Margin peaked at 28.79% during Q2 2025, and registered a low of 26.37% during Q1 2024.
  • In the last 5 years, Pediatrix Medical's FCF Margin had a median value of 14.96% in 2023 and averaged 7.06%.
  • Over the last 5 years, Pediatrix Medical's FCF Margin had its largest YoY gain of 189400bps in 2021, and its largest YoY loss of -464600bps in 2021.
  • Over the past 5 years, Pediatrix Medical's FCF Margin (Quarter) stood at 14.42% in 2021, then rose by 26bps to 18.14% in 2022, then dropped by -29bps to 12.88% in 2023, then surged by 103bps to 26.15% in 2024, then increased by 3bps to 26.94% in 2025.
  • Its FCF Margin stands at 26.94% for Q3 2025, versus 28.79% for Q2 2025 and 26.35% for Q1 2025.